BVSC + Radiation Therapy
BVSC has a comprehensive trilogy of oncology services with surgical, medical and radiation oncology.

EliasGumpelBVSCDr Elias GumpelACVR Certification Mark blue

+ Radiation Oncology Specialist - DVM Diplomate ACVR (RO)

Originally from Buenos Aires, Argentina, Dr. Gumpel spent the past 31 years of his life in the state of Texas in the United States. He attended the University of Texas at Austin, where he graduated with the degree of Bachelor of Science in Biology (Ecology Evolution, Conservation). He was accepted to the the Texas A&M University College of Veterinary Medicine in the year 2000 and graduated in May 2004 with the degree of Doctor of Veterinary Medicine (DVM). Following graduation, he worked as a general practitioner at Fry Road Animal Clinic on the outskirts of Houston from 2004-2008.

Having always had an interest in oncology, Dr. Gumpel was presented the opportunity to specialise in the field by starting an oncology internship at Gulf Coast Veterinary Specialists in Houston, Texas in July 2008. Upon completion of the internship, he accepted a position with GCVS as a radiation oncology resident. The residency program involved training under the supervision of Dr. Glen King (a double-boarded radiologist and radiation oncologist at GCVS), Dr. Mary K. Klein in Tucson, Arizona (a double-boarded medical and radiation oncologist), Dr. Pamela Jones in Phoenix, Arizona (also a double-boarded medical and radiation oncologist), and Wendell Lutz, PhD, a world-renowned medical physicist and one of the original pioneers of stereotactic radiation therapy in humans.

Dr Gumpel is a board certified veterinary radiation oncologist with an on-site, dedicated LINAC for veterinary use.  His expertise greatly contributes towards the improved care of veterinary cancer patients in Australia and surrounding countries.

+ Dr Elias Gumpel with Laila


Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.

Gumpel, E., Moore, A., Simpson, D., Hoffmann, K. and Taylor, D. (2017)
Aust Vet J, 95: 227–231. doi:10.1111/avj.12602

afe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.

Cutrera, J., King, G., Jones, P., Kicenuik, K., Gumpel, E., Xia, X. and Li, S. (2015), S J. Cell.
Mol. Med., 19: 664–675. doi:10.1111/jcmm.12382

Managing Local Swelling Following Intratumoral Electro-Chemo-Gene Therapy.

Methods in Molecular Biology (Clifton, N.J.), 1121, 233–239.

Click Here For Article

Safety and Efficacy of Tumor-targeted Interleukin 12 Gene Therapy in Treated and Non-treated, Metastatic Lesions.

Cutrera, J., King, G., Jones, P., Kicenuik, K., Gumpel, E., Xia, X., & Li, S. (2014)
Current Gene Therapy, 15(1), 44–54.